Read the full press release here.  Advocate Aurora Health and Foxconn Health Technology Business Group announced today a multi-faceted collaboration focused on technology innovations and integration that will drive health care of the future and improve outcomes while lowering costs for individuals and employers. Together the organizations will leverage Foxconn’s emerging technologies coupled with Advocate […]

Read the full post from the Milwaukee Business Journal here!    In the year since the state landed the North American headquarters and massive manufacturing campus of Foxconn Technology Group, Wisconsin rose four places on CNBC’s “America’s Top States for Business” list. Wisconsin rose to No. 17 on the 2018 list after ranking 21st the […]

Finalists Announced for 2018 Wisconsin Innovation Awards Winners to be announced at public awards ceremony on October 3 in Madison Madison— July 12, 2018 — Thirty-four companies and nonprofit organizations have been selected as finalists for the 2018 Wisconsin Innovation Awards. In total, 357 businesses, products and services from around the state were nominated. The […]

Read the full article from Xconomy Wisconsin here.    As TAI Diagnostics presses forward on commercialization of its first product, a test for organ rejection in heart transplant patients, the Wauwatosa, WI-based startup recently revealed additional funding to support development of more tests. TAI Diagnostics is developing a series of non-invasive tests to monitor the […]

Read the full press release here.  Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR), including its Nottingham, U.K.-based Juniper Pharma Services division. When combined with Catalent’s existing industry-leading […]

Read the full press release here.   Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announces that the company will expand patient enrollment in the diffuse large b-cell lymphoma (DLBCL) cohort of its currently enrolling Phase 2 clinical trial of CLR 131. […]

Read the full article by Nick Williams at the Milwaukee Business Journal here.  The growing tech industry in the seven-county Milwaukee area had a $27.6 billion impact on the region in 2017, according to a new study released by Northwestern Mutual Tuesday. The study, called Milwaukee’s Tech Talent Impact, was conducted by Austin, Texas-based TIP Strategies in partnership with […]

Read the full press release here.  Aldevron and Odylia, a nonprofit organization working to develop treatments for ultra-rare ocular diseases using gene therapy, have entered into an agreement in which Aldevron is a member of Odylia. Under this membership agreement, Aldevron will support Odylia’s mission and activities to advance the research, development, manufacture and commercialization […]